Karyopharm Therapeutics Inc. · NASDAQ:KPTI

T. Rowe Price Investment Management, Inc. reported a 8.40% stake in Karyopharm Therapeutics Inc. (Schedule 13G)

Event Jun 30, 2025 · Filed Aug 14, 2025

T. Rowe Price Investment Management, Inc. reported a 8.40% stake in Karyopharm Therapeutics Inc., 728,766 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G).

Stake
8.40%
Shares
728,766
Intent
Passive
What changed
Crossed above 5%

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.8.40%728,766

Source

View original at SEC

Related